Navigation Links
AAPM statement on DEA ruling allowing multiple prescriptions for controlled substances
Date:11/19/2007

GLENVIEW, Ill. The American Academy of Pain Medicine (AAPM) supports todays Drug Enforcement Administration (DEA) ruling, which allows multiple prescriptions for controlled substances when appropriate. This DEA Final Ruling, Issuance of Multiple Prescriptions for Schedule II Controlled Substances, was published in the Federal Register on Monday, Nov. 19, 2007.

AAPM considers this ruling to be a positive indication of recently improved communication between the medical community and law enforcement. Under protest from pain physicians, the DEA had previously disallowed Do Not Fill Until prescriptions for several years. The agencys Final Rule has been eagerly awaited by these concerned physicians who must provide legitimate pain control.

Although not in effect until 30 days from the date of the final ruling on Issuance of Multiple Prescriptions for Schedule II Controlled Substances, this rule change allows physicians to write three separate prescriptions with staggered fill dates. Patients can still be given the equivalent of a 90-day prescription for schedule II controlled substances when medically appropriate. Schedule II drugs are those that have recognized medical uses as well as a potential for dependence and abuse. Consequently, these drugs are carefully controlled and regulated by the DEA.

This welcome policy reversal by the DEA has eliminated the burden previously imposed on patients with cancer or chronic pain who were forced to visit their physician every month for new pain medicine prescriptions when there was no medical necessity to do so. The DEA now allows physicians to use their professional judgment to carefully control the amount of a controlled substance issued to a patient at one time. Do Not Fill Until prescriptions offer increased control, safety and convenience, and may be issued in small increments for at-risk patients, or by the month to comply with insurance reimbursement regulations.

With todays Final Rule, the DEA has recognized the need for policies that support effective control of potentially abusable drugs that do not unnecessarily hinder the appropriate treatment of pain. On behalf of all legitimate patients with pain, AAPM continues to address and debate policies that address the dual crises of prescription drug abuse and undertreated pain. AAPM is committed to safe and effective treatment of pain and to effective policy on prescription drug abuse.


'/>"/>

Contact: Amy Jenkins
amy@jenkinspr.com
312-371-8365
American Academy of Pain Medicine
Source:Eurekalert

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
3. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
4. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
5. Statement by Oscar S. Wyatt, Jr.
6. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
7. Pelosi Statement on Proposed Entitlement Task Force
8. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
9. Statement on House/Senate Agreement on SCHIP Legislation
10. Statement from the Alliance for Quality Nursing Home Care
11. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... Coco Libre, the maker of ... Carpet Events LA GRAMMY’s Style Lounge Event. Coco Libre will offer musicians and celebrities ... before the big event. The invitation-only gifting suite, held this year at the W ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... (WaaS), today announced the integration of Clarity Intelligence Platform (CIP) into Cielo®, a ... offer real-time business intelligence (BI) to their small and medium business (SMB) clients. ...
(Date:2/12/2016)... NC (PRWEB) , ... February 12, 2016 , ... AssureVest ... surrounding areas, is initiating a charity drive that will raise funds earmarked to purchase ... John C. Tayloe Elementary School. , “My school is in a low-income area and ...
(Date:2/12/2016)... ... , ... Erlanger Agency has announced a new partnership in its ongoing community ... on the fight against breast cancer, fundraising for a local woman named Carmen, who ... Carmen is a loving single mother of two boys who also serves as caregiver ...
(Date:2/12/2016)... ... February 12, 2016 , ... Miami Dental Specialists is excited to bring patients ... office. Beginning in January, Miami Dental Specialists will offer the non-metal implants as a ... office to be chosen by the dental implant manufacturer, Straumann, to bring this cutting-edge ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... 12, 2016  Apellis Pharmaceuticals, Inc., today ... million Series D preferred stock financing, co-led ... Capital Group and venBio Global Strategic Fund, ... IB Investment, and Epidarex Capital. The proceeds of ... advance clinical trials in the Company,s ongoing ...
(Date:2/11/2016)... -- - Cardiac Marker Diagnostic Testing ... Cancer Therapy. - European Point of Care Diagnostic ... - Key Diagnostic Testing Markets. - Molecular Diagnostics ... Testing. - Molecular Diagnostics in Infectious Disease Testing. ... Products World Markets. - Point of Care Diagnostic ...
(Date:2/11/2016)... INC. (NasdaqCM: PDEX) today announced financial results for its fiscal ... filed its Quarterly Report on Form 10-Q for the second ... Commission today. --> --> ... --> Net sales for the three months ended ... million from $2.8 million for the three months ended December ...
Breaking Medicine Technology: